Please login to the form below
Regeneron
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Regeneron's Japan sales performance.
Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the European Commission as the first and only targeted medicine for eosinophilic oesophagitis (EoE), the companies announced.
Sanofi/Regeneron’s Dupixent recommended by CHMP for atopic dermatitis in children
Sanofi and Regeneron’s Dupixent (dupilumab) has been recommended for use in the EU to treat severe atopic dermatitis in children aged six months to five years who are candidates for ... this chronic disease," George Yancopoulos, Regeneron’s president
Moderna and CytomX to partner in deal worth up to 1.2bn
In November 2022, the company announced a collaboration and licensing agreement with Regeneron to create conditionally-activated investigational bispecific cancer therapies. ... The partnership will also utilise the company’s Probody platform, along
Sanofi/ Regeneron’s Dupixent recommended by CHMP to treat eosinophilic oesophagitis
Sanofi and Regeneron’s Dupixent (dupilumab) has been recommended by the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) to treat adults and adolescent patients
Sanofi and Regeneron’s Dupixent granted EC approval for prurigo nodularis
Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the European Commission (EC) for the treatment of adult patients with moderate-to-severe prurigo nodularis who are candidates for systemic ... devastating impact on their day-to-day lives,
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- Eli Lilly announces $450m investment in US manufacturing site
- Sanofi/Regeneron’s Dupixent recommended by CHMP for atopic dermatitis in children
- Sandoz’s high concentration Hyrimoz formulation recommended for use in EU
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- GSK to submit drug application for new antibiotic to US FDA
- EU outlines measures to mitigate antibiotic shortage across Europe
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Neurodiversity and healthcare communications – do we know enough and do we do enough?
PMHub
Redbow Consulting Group
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
